abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Total Costs & Expenses
-$69.85M
TTM · Period ending: · USD
HQL Total Costs & Expenses
Latest reported-$69.85Mperiod ending
Latest reported-$69.85Mperiod ending
HQL TTM Total Costs & Expenses ($3.75M → -$69.85M)
TTM Total Costs & Expenses
High-resolution chart · PNG
HQL total costs & expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Total Costs & Expenses (USD) |
|---|---|
| -69,850,324 | |
| -49,861,675 | |
| 112,345,151 | |
| 49,782,194 | |
| 96,598,269 | |
| 180,349,775 | |
| 122,345,999 | |
| 116,953,487 | |
| -9,419,279 | |
| -103,506,956 | |
| -83,883,852 | |
| -78,672,905 | |
| 517,455 | |
| 10,912,558 | |
| 8,322,262 | |
| 5,659,806 | |
| 2,901,062 | |
| 193,536 | |
| 204,052 | |
| 268,620 | |
| 265,330 | |
| 230,344 | |
| 237,354 | |
| 159,651 | |
| 21,819,713 | |
| 75,556,860 | |
| 77,683,460 | |
| 79,855,597 | |
| 60,032,167 | |
| 8,149,999 | |
| 7,769,999 | |
| 7,389,999 | |
| 7,790,000 | |
| 8,190,000 | |
| 8,680,000 | |
| 9,170,000 | |
| 8,700,000 | |
| 8,230,000 | |
| 7,670,000 | |
| 7,110,000 | |
| 6,985,000 | |
| 6,860,000 | |
| 6,600,000 | |
| 6,340,000 | |
| 6,370,000 | |
| 6,400,000 | |
| 6,780,000 | |
| 7,160,000 | |
| 6,375,000 | |
| 5,590,000 | |
| 4,665,000 | |
| 3,740,000 | |
| 3,745,000 | |
| 3,749,999 |